Showing results (441-450 of 27,668) with videos related to
Sort By:
Pageof 2,767
Vaccine|August 15, 2015
Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challengeBrock Kingstad-Bakke, Attapon Kamlangdee, Jorge E OsorioVaccine|February 1, 1989
Involvement of T cells in malaria immunity: implications for vaccine developmentM F Good, L H MillerVaccine|October 14, 2015
Superoxide dismutase SodB is a protective antigen against Campylobacter jejuni colonisation in chickensCosmin Chintoan-Uta, Robin L Cassady-Cain, Halah Al-Haideri, et al.Vaccine|October 14, 2015
Maternal immunization efforts of the National Institutes of HealthFran A Rubin, Marion Koso-Thomas, Maggie Brewinski Isaacs, et al.Vaccine|October 14, 2015
Analysis of cell-mediated immune responses in support of dengue vaccine development effortsAlan L Rothman, Jeffrey R Currier, Heather L Friberg, et al.Vaccine|October 14, 2015
Particle-based platforms for malaria vaccinesYimin Wu, David L Narum, Sylvain Fleury, et al.Vaccine|October 24, 2013
Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditionsBo-Hyun Cho, Charles Stoecker, Ruth Link-Gelles, et al.Vaccine|October 24, 2013
RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly populationM J Meijboom, K B Pouwels, W Luytjes, et al.Vaccine|October 23, 2013
Effectiveness of 2+1 PCV7 vaccination schedules in children under 2 years: a meta-analysis of impact studiesKatharina Schönberger, Katja Kirchgässner, Christina Riedel, et al.Vaccine|October 23, 2013
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled studyThomas Harrer, Andreas Plettenberg, Keikawus Arastéh, et al.Pageof 2,767